Evidence map›Paper›PMID 36750295›Full record

ArticleBMJ case reports2023

Successful outcome in a compound heterozygote haemoglobin E/beta-thalassaemia in pregnancy.

Kalika Dubey, Charu Sharma, Suma Shet, Shashank Shekhar

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kalika DubeyObstetrics & Gynaecology, All India Institute of Medical Sciences, Jodhpur, India.ORCID http://orcid.org/0000-0002-3764-2424
Charu SharmaObstetrics & Gynaecology, All India Institute of Medical Sciences, Jodhpur, India sharma.charu651@gmail.com.ORCID http://orcid.org/0000-0002-7788-2502
Suma ShetObstetrics & Gynaecology, All India Institute of Medical Sciences, Jodhpur, India.
Shashank ShekharObstetrics & Gynaecology, All India Institute of Medical Sciences, Jodhpur, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Haemoglobin E (HbE) affects at least 1 million people around the world. The carrier frequency of HbE/beta-thalassaemia (HbE/β-thalassaemia) is highest in Southeast Asia. In India, the highest frequency is observed in the northeast region. Distinguishing between homozygous HbE disease and HbE/β-thalassaemia is a challenge to the haematopathologist as well as to the treating obstetrician because both are clinically and haematologically similar, posing a difficulty in managing anaemia and assessing the fetal risk for the same disease. This article reports a case of compound heterozygote HbE/β-thalassaemia in pregnancy and its successful outcome.

Indexed as

beta-ThalassemiaHemoglobin EThalassemiaFemaleHeterozygoteHumansIndiaPregnancyHemoglobin Egeneticsgenetic screening / counsellinghaematology (drugs and medicines)haematology (incl blood transfusion)obstetrics, gynaecology and fertility

Identifiers

PMID36750295
PMCPMC9906172

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.